Year Founded
2021
Ownership
Private
Employees
~10
Stage
Preclinical
Modalities
Protein therapeuticsSynthetic proteinSynthetic biology

AINovo Biotech General Information

Company uses AI platform to accelerate R&D in agriculture and human health, reducing development costs by up to 70%. Recently partnered with HM Clause and Vilmorin Mikado for agricultural applications.

Contact Information

Website
Primary Industry
Biotech
Corporate Office

Drug Pipeline

No pipeline data available

For full access to AINovo Biotech's pipeline data

Book a demo

Key Partnerships

HM Clause, Vilmorin Mikado, Limagrain

Need more data on over 80,000 life science companies, including over 1200 biotechs?

Book a demo

AINovo Biotech Funding

No funding data available

Early Stage VC (Series A)04-Jun-2020$38MCompletedPhase 1
Seed Round12-Feb-2019$8.5MCompletedStartup

Interested in comprehensive profile data?

We'll help you find what you need

Learn more
To view AINovo Biotech's complete valuation and funding history, request access »